NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
NEUTRA CORP.
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0001 (−50.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
NEUTRA CORP. saw revenue fall 82.7% to $17.40K over the twelve months to Oct 31, 2023.
Revenue
$17.40K
-82.7% vs. a year earlier
Operating income
-$253.49K
TTM Q3 2024
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Oct 31, 2023
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $17.40K
- Net income
- -$473.83K
Thirteen years at a glance
Fiscal years 2011 to 2023 and trailing twelve months, USD
Revenue
$17.40K-82.7% YoY
Gross profit
$8.03K-86.9% YoY
Operating income
-$253.49K
Net income
-$473.83K
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months